Pseudoprogression and hyperprogression secondary to immunotherapy in lung cancer

BACKGROUND: The treatment of non-small cell lung cancer (NSCLC) has undergone changes that have improved the prognosis of patients. With the advent of immunotherapy, it has been possible to prolong significantly the overall and progression-free survival as well as quality of life. Nevertheless, its...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	R. Riera-Sala, A. Ibarra-Morales, J. Guzmán-Casta, R. Medrano-Guzmán, A. Dip-Borunda, A. Martin-Aguilar, R. Grajales-Álvarez, R. Correa-Cano, K. Elvira-Fabián, C. Sánchez-Ríos, A. Orzuna-Vázquez, J. Rovelo-Lima, L. Martínez-Barrera, J. Rodríguez-Cid, J. Alatorre-Alexander
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Verduci Editore 2023-09-01
Cyfres:	World Cancer Research Journal
Pynciau:	pseudoprogression hyperprogression immunotherapy lung cancer
Mynediad Ar-lein:	https://www.wcrj.net/wp-content/uploads/sites/5/2023/09/e2660.pdf
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!